NCT00514215View on ClinicalTrials.gov

Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Kidney CancerLung CancerMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

sargramostim

250 μg, inhaled, two times a day, on days 4-10 and days 36-42

OTHER

flow cytometry

Days 1 \& 32

OTHER

immunoenzyme technique

Days 1 \& 32

PROCEDURE

biopsy

CT guided biopsy on days 1 \& 32

PROCEDURE

cryosurgery

Days 1 and 32

Trial Locations (1)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00514215 - Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer | Biotech Hunter | Biotech Hunter